 Milenkov M. et al.
Prevalence, Risk Factors, and Genetic Characterization of Extended-Spectrum Beta-Lactamase Escherichia coli Isolated From Healthy Pregnant Women in Madagascar.
Front. Microbiol. 2021 Dec 24 |
|
 Lebourgeois S. et al.
Earlier In Vitro Viral Production With SARS-CoV-2 Alpha Than With Beta, Gamma, B, or A.27 Variants.
Front. Cell. Infect. Microbiol. 2021 Dec 16 |
|
 Meyer A. et al.
HSV-1 reactivation is associated with an increased risk of mortality and pneumonia in critically ill COVID-19 patients.
Crit. Care 2021 Dec 6 |
|
 Bizot E. et al.
Azithromycin resistance in Shiga-toxin Producing Escherichia coli in France between 2004 and 2020 and detection of mef(C)- mph(G) genes.
Antimicrob. Agents Chemother. 2021 Dec 6 |
|
 Epelboin S. et al.
Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
PLoS Med. 2021 Nov 30 |
|
 Tabah A. et al.
Current opinion in management of septic shock due to Gram-negative bacteria.
Curr Opin Infect Dis. 2021 Dec 1 |
|
 Papot E. et al.
Can we talk about price with patients when choosing antiretroviral therapy? A survey with people living with HIV and prescribers in France.
BMJ Open. 2021 Nov 26 |
|
 Lebourgeois S. et al.
Alpha (B.1.1.7) and Delta (B.1.617.2 – AY.40) SARS-CoV-2 variants present strong neutralization decay at M4 post-vaccination and a faster replication rates than D614G (B.1) lineage.
J. Infect. 2021 Nov 19 |
|
 Saliba R. et al.
Significant variation in the fecal relative abundance of carbapenemase-producing-Enterobacteriaceae of colonized patients during hospitalization: a preliminary study.
Int. J. Antimicrob. Agents. 2021 Nov 18 |
|
 Lê M.P. et al.
Bictegravir pharmacokinetics in a late-presenting HIV-1-infected pregnant woman: a case report.
J. Antimicrob. Chemother. 2021 Nov 18 |
|
Le Hingrat Q. et al.
In vitro analysis of the replicative capacity and phenotypic susceptibility to integrase inhibitors of HIV-2 mutants with integrase insertions.
J Antimicrob Chemother. 2021 Nov 6 |
|
Le Menestrel A. et al.
Activity of the combination of colistin and fosfomycin against NDM-1-producing Escherichia coli with variable levels of susceptibility to colistin and fosfomycin in a murine model of peritonitis.
J Antimicrob Chemother. 2021 Oct 29 |
|
 Fiolet T. et al.
Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: A narrative review.
Clin Microbiol Infect. 2021 Oct 26 |
|
 Maisonnasse P. et al.
COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models.
Nat. Commun. 2021 Oct 20 |
|
 Passemard S. et al.
Covid-19 crisis impact on the next generation of physicians: a survey of 800 medical students.
BMC Med. Educ. 2021 Oct 13 |
|
 Massot M. et al.
Interplay between bacterial clone and plasmid in the spread of antibiotic resistance genes in the gut: lessons from a temporal study in veal calves.
Appl. Environ. Microbiol. 2021 Oct 6 |
|
Ferré V.M. et al.
Decreasing humoral response among healthcare workers up to 4 months after two doses of BNT162b2 vaccine.
J. Infect. 2021 Sep 29 |
|
 Bizot E. et al.
Improved molecular diagnosis and culture of the emerging heteropathotype enterohemorrhagic Escherichia coli O80:H2 using its non-melibiose-fermenting and antibiotic-resistance properties.
J. Clin. Microbiol. 2021 Sep 29 |
|
 Marc A. et al.
Quantifying the relationship between SARS-CoV-2 viral load and infectiousness.
Elife 2021 Sep 27 |
|
Bouzid D. et al.
Added value of rapid respiratory syndromic testing at point of care versus central laboratory testing: a controlled clinical trial.
J. Antimicrob. Chemother. 2021 Sep 23 |
|
 Castry M. et al.
Hepatitis C virus (HCV) incidence among men who have sex with men (MSM) living with HIV: results from the French Hospital Database on HIV (ANRS CO4-FHDH) cohort study, 2014 to 2017.
Euro Surveill. 2021 Sep 23 |
|
Blanquart F. et al.
Characterisation of vaccine breakthrough infections of SARS-CoV-2 Delta and Alpha variants and within-host viral load dynamics in the community, France, June to July 2021.
Euro Surveill. 2021 Sep 16 |
|
 Ader F. et al.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Lancet Infect. Dis. 2021 Sep 14 |
|
 Deruelle P. et al.
Prenatal care providers’ perceptions of the SARS-Cov-2 vaccine for themselves and for pregnant women.
PLoS One 2021 Sep 13 |
|
 Eloy P. et al.
Severity of self-reported symptoms and psychological burden 6-months after hospital admission for COVID-19: a prospective cohort study.
Int. J. Infect. Dis. 2021 Sep 10 |
|
 Benadji A. et al.
Relationship between serotypes, disease characteristics and 30-day mortality in adults with invasive pneumococcal disease.
Infection 2021 Sep 1 |
|
 Kernéis S. et al.
Accuracy of saliva and nasopharyngeal sampling for detection of SARS-CoV-2 in community screening: a multicentric cohort study.
Eur. J. Clin. Microbiol. Infect. Dis. 2021 Aug 31 |
|
 Telford E. et al.
Chronicles of a pandemic: how France coordinated the scientific research response to COVID-19.
Infect. Dis. Now 2021 Aug 28 |
|
Birgy A. et al.
Clavulanate combinations with mecillinam, cefixime or cefpodoxime against ESBL-producing Enterobacterales frequently associated with blaOXA-1 in a paediatric population with febrile urinary tract infections.
J. Antimicrob. Chemother. 2021 Aug 28 |
|
 Petitjean M. et al.
Phylum barrier and Escherichia coli intra-species phylogeny drive the acquisition of antibiotic-resistance genes.
Microb. Genom. 2021 Aug 26 |
|
 Bonnet R. et al.
Host colonization as a major evolutionary force favoring the diversity and the emergence of the worldwide multidrug-resistant Escherichia coli ST131.
mBio. 2021 Aug 24 |
|
Sokal A. et al.
Specificities of acute cholangitis in patients with cancer: a retrospective comparative study of 130 episodes.
Eur. J. Clin. Microbiol. Infect. Dis. 2021 Aug 20 |
|
 Mullaert J. et al.
Taking population stratification into account by local permutations in rare-variant association studies on small samples.
Genet. Epidemiol. 2021 Aug 17 |
|
Dupuis C. et al.
Impact of early corticosteroids on 60-day mortality in critically ill patients with COVID-19: A multicenter cohort study of the OUTCOMEREA network.
PLoS One 2021 Aug 4 |
|
 Duval X. et al.
Impact of Systematic Whole-body 18F-Fluorodeoxyglucose PET/CT on the Management of Patients Suspected of Infective Endocarditis: The Prospective Multicenter TEPvENDO Study.
Clin. Infect. Dis. 2021 Aug 2 |
|
 Ghelfenstein-Ferreira T. et al.
An Educational Game Evening for Medical Residents: A Proof of Concept to Evaluate the Impact on Learning of the Use of Games.
JMBE 2021 Jul 30 |
|
 D’Humières C. et al.
The Potential Role of Clinical Metagenomics in Infectious Diseases: Therapeutic Perspectives.
Drugs. 2021 Jul 30 |
|
Armand-Lefèvre L. et al.
Dynamics of extended-spectrum beta-lactamase-producing Enterobacterales colonization in long-term carriers following travel abroad.
Microb. Genom. 2021 Jul 19 |
|
Chauffour A. et al.
A systematic review of Mycobacterium leprae DNA gyrase mutations and their impact on fluoroquinolone resistance.
Clin. Microbiol. Infect. 2021 Jul 12 |
|
 Martin A. et al.
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings.
J. Clin. Virol. 2021 Jul 3 |
|
Royer G. et al.
Lack of association between colistin resistance and chlorhexidine reduced susceptibility in clinical isolates of Escherichia coli.
J. Antimicrob. Chemother. 2021 Jul 10 |
|
 Ghosn J. et al.
HIV-1-RNA kinetics in blood plasma and in seminal plasma of men starting a dolutegravir-based triple-combination regimen at the time of primary HIV-1 infection.
J. Infect. Dis. 2021 Jun 24 |
|
Lê M.P. et al.
Placental transfer of doravirine, a recent HIV-1 NNRTI in the ex vivo human cotyledon perfusion model.
J. Antimicrob. Chemother. 2021 Jun 21 |
|
 Fouéré S. et al.
Update on French recommendations for the treatment of uncomplicated Neisseria gonorrhoeae infections.
Int. J. STD. AIDS. 2021 Jun 14 |
|
Bachelard A. et al.
Efficacy and tolerability of combined antiretroviral treatment with bictegravir/ emtricitabine/ tenofovir alafenamide initiated at the time of primary HIV infection.
J. Antimicrob. Chemother. 2021 Jun 10 |
|
 Husain M. et al.
Impact of the COVID-19 pandemic on the homeless: results from a retrospective closed cohort in France (March-May 2020).
Clin. Microbiol. Infect. 2021 Jun 7 |
|
 Crawford C. et al.
Modeling of aerosol transmission of airborne pathogens in ICU rooms of COVID-19 patients with acute respiratory failure.
Sci. Rep. 2021 Jun 3 |
|
 Comets E. et al.
Conditional Non-parametric Bootstrap for Non-linear Mixed Effect Models.
Pharm. Res. 2021 Jun 1 |
|
Ader F. et al.
An open-label randomized, controlled trial of the effect of lopinavir/ritonavir, lopinavir/ritonavir plus IFN-β-1a and hydroxychloroquine in hospitalized patients with COVID-19.
Clin. Microbiol. Infect. 2021 May 25 |
|
 Commets E. et al.
Developing Tools to Evaluate Non-linear Mixed Effect Models: 20 Years on the npde Adventure.
CAAPS J. 2021 May 19 |
|
Royer G. et al.
O-antigen targeted vaccines against E. coli may be useful in reducing morbidity, mortality and antimicrobial resistance.
Clin. Infect. Dis. 2021 May 17 |
|
 Manchon P. et al.
Evaluation by simulation of clinical trial designs for evaluation of treatment during a viral haemorrhagic fever outbreak.
BMC Med. Res. Methodol. 2021 May 6 |
|
 Royer G. et al.
Phylogroup stability contrasts with high within sequence type complex dynamics of Escherichia coli bloodstream infection isolates over a 12-year period.
Genome Med. 2021 May 5 |
|
 Couffignal C. et al.
Impact of study design and statistical model in pharmacogenetic studies with gene-treatment interaction.
CPT Pharmacometrics Syst. Pharmacol. 2021 May 5 |
|
d’Humières C. et al.
Two original observations concerning bacterial infections in COVID-19 patients hospitalized in intensive care units during the first wave of the epidemic in France.
PLoS One 2021 Apr 29 |
|
Zeller V. et al.
Influence of the clindamycin-administration route on the magnitude of clindamycin-rifampicin interaction: a prospective pharmacokinetic study.
Clin. Microbiol. Infect. 2021 Apr 25 |
|
Hobson C.A. et al.
Cross resistance to cefiderocol and ceftazidime-avibactam in KPC beta-lactamase mutants and inoculum effect.
Clin. Microbiol. Infect. 2021 Apr 25 |
|
Lebourgeois S. et al.
Performance Evaluation of the QIAstat-Dx® Respiratory SARS-CoV-2 Panel.
Int. J. Infect. Dis. 2021 Apr 23 |
|
 Ghazali DA. et al.
Analysis of the Feasibility of a Vaccination Campaign against Influenza Epidemic and COVID-19 Pandemic in French Emergency Departments: A National Survey.
Vaccines (Basel) 2021 Apr 19 |
|
 Ben M’Barek I. et al.
Contribution of vaginal culture to predict early onset neonatal infection in preterm prelabor rupture of membranes.
Eur. J. Obstet. Gynecol. Reprod. Biol. 2021 Apr 16 |
|
Betton M. et al.
Sera neutralizing activities against SARS-CoV-2 and multiple variants six month after hospitalization for COVID-19.
Clin. Infect. Dis. 2021 Apr 14 |
|
 Bizot E. et al.
Shiga toxin-producing Escherichia coli carriage in 959 healthy French infants.
Arch. Dis. Child. 2021 Apr 8 |
|
Vauloup-Fellous C. et al.
Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
Eur. J. Clin. Microbiol. Infect. Dis. 2021 Mar 29 |
|
 Gonçalves A. et al.
SARS-CoV-2 viral dynamics in non-human primates.
PLoS Comput. Biol. 2021 Mar 17 |
|
Maataoui N. et al.
Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit.
Eur. J. Clin. Microbiol. Infect. Dis. 2021 Mar 17 |
|
 Maataoui N. et al.
HIV-2 diversity displays two clades within group A with distinct geographical distribution and evolution.
Virus Evol. 2021 Mar 16 |
|
Gaymard A. et al.
Early assessment of diffusion and possible expansion of SARS-CoV-2 Lineage 20I/501Y.V1 (B.1.1.7, variant of concern 202012/01) in France, January to March 2021.
Euro Surveill. 2021 Mar 4 |
|
 Lescure F.X. et al.
Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Respir. Med. 2021 Mar 4 |
|
 Buatois S. et al.
cLRT-Mod: An efficient methodology for pharmacometric model-based analysis of longitudinal phase II dose finding studies under model uncertainty.
Stat. Med. 2021 Mar 2 |
|
Czuppon P. et al.
Success of prophylactic antiviral therapy for SARS-CoV-2: Predicted critical efficacies and impact of different drug-specific mechanisms of action.
PLoS Comput. Biol. 2021 Mar 1 |
|
 Néant N. et al.
Modeling SARS-CoV-2 viral kinetics and association with mortality in hospitalized patients from the French COVID cohort.
Proc. Natl. Acad. Sci. USA 2021 Feb 23 |
|
Chawki S. et al.
Temocillin as an alternative treatment for acute bacterial cholangitis: a retrospective microbiology susceptibility-based study of 140 episodes.
Eur. J. Clin. Microbiol. Infect. Dis. 2021 Feb 20 |
|
Pascucci M. et al.
AI-based mobile application to fight antibiotic resistance.
Nat. Commun. 2021 Feb 19 |
|
 Saliba R. et al.
Risk Factors for the Environmental Spread of Different Multi-Drug-Resistant-Organisms (MDRO): A Prospective Cohort Study.
J. Hosp. Infect. 2021 Feb 10 |
|
Tarhini H. et al.
Long term SARS-CoV-2 infectiousness among three immunocompromised patients: from prolonged viral shedding to SARS-CoV-2 superinfection.
J. Infect. Dis. 2021 Feb 8 |
|
Tubiana S. et al.
High-risk exposure without personal protective equipment and infection with SARS-CoV-2 in-hospital workers – The CoV-CONTACT cohort.
J. Infect. 2021 Feb 3 |
|
 Flament H. et al.
Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity.
Nat. Immunol. 2021 Feb 2 |
|
 Contejean A. et al.
Comparing Dynamics and Determinants of Severe Acute Respiratory Syndrome Coronavirus 2 Transmissions Among Healthcare Workers of Adult and Pediatric Settings in Central Paris.
Clin. Infect. Dis. 2021 Jan 27 |
|
 Buetti N. et al.
COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
Intensive Care Med. 2021 Jan 27 |
|
 Rousset F. et al.
The impact of genetic diversity on gene essentiality within the Escherichia coli species.
Nat. Microbiol. 2021 Jan 18 |
|
Dupuis C. et al.
Burden of pneumococcal pneumonia requiring ICU admission in France: 1-year prognosis, resources use, and costs.
Crit. Care 2021 Jan 10 |
|
Lingas G. et al.
Lassa viral dynamics in non-human primates treated with favipiravir or ribavirin.
PLoS Comput Biol. 2021 Jan 7 |
|
![]()
 Bridier-Nahmias A. et al.
Escherichia coli Genomic Diversity within Extraintestinal Acute Infections Argues for Adaptive Evolution at Play.
mSphere 2021 Jan 6 |
PREVIOUS EVENTS
Couce A.et al.
Sokal A. et al.
Senelle G. et al.
Sahal MR. et al.
Choudhury A. et al.
Gaschignard J. et al.
Sylvie C. et al.
Burgaya J. et al.
Henoun Loukili N. et al.
Tardivon C. et al.
Gamblin J. et al.
Maalej NH. et al.
Chosidow S. et al.
Senelle G. et al.
Castry M. et al.
Rondinaud E. et al.
Magréault S. et al.
Ferré VM. et al.
Billard-Pomares T. et al.
Hobson CA. et al.
Claessens YE. et al.
Molina JM. et al.
Rybak A.et al.
Rybak A.et al.
Martin-Blondel G. et al.
Ghazali DA.et al.
Contejean A.et al.
Lo S.et al.
Le Hingrat Q.et al.
Congo-Ouedraogo M.et al.
Guyeux C. et al.
de Lastours V. et al.
Choudhury A. et al.
Le Hingrat Q. et al.
Lecuru M. et al.
Castry M. et al.
Gonçalves A. et al.
Yazdanpanah Y. et al.
Duprilot M. et al.
Isernia V. et al.
Massot M. et al.
Denamur E. et al.
Grzelak L. et al.
Atlani-Duault L. et al.
Poline J. et al.
Maisonnasse P. et al.
Canovas J. et al.
Ouldali N. et al.
Kemble H. et al.
Jacquier H. et al.
Jouvin-Marche E. et al.
Sallard E. et al.
Lescure FX. et al.
Choudhury A. et al.
Peiffer-Smadja N. et al.
Hobson CA et al.
Le Hingrat Q. et al.
Jacquier H. et al.
Mentré F. et al.
Eholie S. et al.
Tubiana S. et al.
Ghalayini M. et al.
Loubet P. et al.
Seurat J. et al.
